Carlisle Companies (NYSE:CSL) announced today that it has completed its acquisition of Providien for an undisclosed amount. San Diego-based Providien provides solutions for global medical technology OEMs, such as contract manufacturing, precision machining and metals, thermoforming and injection molding. The acquisition, which was initially announced last month, is part of Scottsdale, Ariz.-based Carlisle’s plan to […]
Stent makers point to quality-of-life findings by massive federal study
The giant federal study that found the use of stents in stable heart-disease patients is no better than drugs to treat clogged arteries reached another, less-hyped conclusion. Manufacturers of stents for percutaneous coronary intervention (PCI) note that the Ischemia study also concluded that patients who undergo a stenting procedure have a better quality of life. They suffer […]
Abiomed stock recovers some as company further questions critical Impella studies
Shares of heart pump company Abiomed (NSDQ:ABMD) recovered a bit today — a day after the company’s stock took a 20% dive after two critical studies came out of American Heart Association’s Scientific Sessions. The two separate studies — one led by researchers in St. Louis, the other out of San Francisco — suggested potentially serious complications […]
Getinge shares drop on news of more deaths, injuries linked to faulty IABPs
Shares of Getinge (STO:GETI-B) dropped 5% today on news that the FDA had received 60 more reports of adverse events — including two deaths and one serious injury — related to the company’s Maquet/Datascope intraortic balloon pumps (IABP). The FDA said the new reports have come in since it issued a letter in November 2018 […]
FDA approves CooperVision’s contact lens to slow nearsightedness in kids
The FDA has approved the first contact lens indicated to slow the progression of nearsightedness in children between the ages of 8 and 12 years old. The MiSight contact by CooperCompanies’ (NYSE:COO) CooperVision lens is a single-use, disposable, soft contact lens that is discarded at the end of each day and is not intended to be worn […]
Medtronic Q2 results beat The Street
Medtronic (NYSE:MDT) posted second-quarter results today that beat the consensus forecast on Wall Street and reiterated its outlook for the rest of the fiscal year. The Fridley, Minn.–based company reported profits of $1.4 billion, or $1.01 per share, on sales of $7.7 billion for the three months ended Oct. 25, 2019, for a bottom-line gain of […]
BREAKING: Abiomed stock down 20% after new research raises questions about Impella
Shares of heart pump company Abiomed (NSDQ:ABMD) fell today after research released over the weekend suggested potentially serious complications involving the company’s Impella heart pumps. Abiomed stock was down more than 20%, to $178.09 per share, by the close of trading after news of the two studies came out of the American Heart Association’s Scientific Sessions […]
ReShape loses profits, grows sales in Q3
ReShape Lifesciences (OTC:RSLS) posted large bottom-line losses in the third quarter, despite a big leap in sales growth. The San Clemente, Calif.–based obesity and metabolic disease treatment developer posted losses of -$28.8 million, or $-106.55 per share, on sales of $3.5 million for the three months ended Sept. 30, for a massive bottom-line slide on […]
Axonics slides on earnings, misses on revenue in Q3 results
Axonics Modulation Technologies (NSDQ:AXNX) posted third-quarter results today that missed the consensus forecast on Wall Street. The Irvine, Calif.-based company posted losses of $25 million, or -89¢ per share, on sales of $1.3 million for the three months ended Sept. 30, 2019, for a bottom-line loss of 228.9% sales growth of 546.8% compared with Q3 2018. […]
ReWalk Robotics posts Q3 losses on missed projections
ReWalk Robotics (NSDQ:RWLK) reported third-quarter results that came up shy of the consensus forecast. The Yokneam Illit, Israel–based robotic walking assistance company posted losses of -$3.4 million, or -46¢ per share, on sales of $1.2 million for the three months ended Sept. 30, for a 25.2% bottom-line gain on sales decline of -23.7%. Adjusted to exclude […]
iRhythm Technologies won’t file 10-Q, citing material weaknesses
iRhythm Technologies (NSDQ:IRTC) this week said it would not be filing its quarterly report on Form 10-Q, citing previously disclosed material weaknesses, according to an SEC filing. The San Francisco-based company said it identified errors that affected prior periods while preparing the quarterly report for the period ended Sept. 30, 2019. The errors could affect the […]
- 1
- 2
- 3
- …
- 555
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube